| Literature DB >> 26123873 |
Abstract
We review the futility clinical trial design (also known as the non-superiority design) with respect to its emergence and methodologic developments over the last decade, especially in regard to its application to clinical trials for neurological disorders. We discuss the design's strengths as a programmatic screening device to weed out unpromising new treatments, its limitations and pitfalls, and a recent critique of the logic of the method.Entities:
Keywords: Futility design; Non-superiority design; Phase II trials; Screening program
Mesh:
Year: 2015 PMID: 26123873 PMCID: PMC4639404 DOI: 10.1016/j.cct.2015.06.013
Source DB: PubMed Journal: Contemp Clin Trials ISSN: 1551-7144 Impact factor: 2.226